Today's Hours: 8:00am - 8:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Duane R. Hospenthal, Michael G. Rinaldi, editors.
    Contents:
    Part One Approach to Patients
    Chapter 1 Approach to Patients with Suspected Fungal Infections
    Part Two Laboratory and Radiological Diagnosis
    Chapter 2 Basic Mycology
    Chapter 3 Diagnostic Molecular Biology
    Chapter 4 Diagnostic Histopathology
    Chapter 5 Diagnostic Immunology
    Chapter 6 Diagnostic Radiology
    Part Three Antifungal Agents
    Chapter 7 Antifungal Agents
    Part Four Mycoses
    Chapter 8 Candidiasis
    Chapter 9 Infection Due to non-Candidal Yeasts
    Chapter 10 Aspergillosis
    Chapter 11 Hyalohyphomycosis
    Infection Due to Hyaline Moulds
    Chapter 12 Phaeohyphomycosis
    Infection Due to Dark (Dematiaceous) Moulds
    Chapter 13 Mucormycosis (Zygomycosis)
    Chapter 14 Pneumocystosis
    Chapter 15 Cryptococcosis
    Chapter 16 Blastomycosis
    Chapter 17 Coccidioidomycosis
    Chapter 18 Histoplasmosis
    Chapter 19 Paracoccidioidomycosis
    Chapter 20 Sporotrichosis
    Chapter 21 Dermatophytosis (Tinea) and Other Superficial Fungal Infections
    Chapter 22 Fungal Infections of Implantation (Chromoblastomycosis, Mycetoma, Entomophthoramycosis and Lacaziosis)
    Part Five Instructive Cases. Instructive Cases
    Instructive Cases Discussion.
    Digital Access Springer 2015
  • Article
    Henrikson PA, Tjernberg A, Ahlström U, Peterson LE.
    J Int Med Res. 1979;7(2):107-16.
    In a double-blind clinical trial a new, non-steroidal anti-inflammatory agent with analgesic properties, Fenbufen, was compared to acetylsalicylic acid (ASA) and placebo. Six hundred (600) out-patients, following surgical removal of an impacted lower wisdom tooth, were divided into three groups and randomly given either Fenbufen (500 mg capsules), ASA (750 mg capsules), or placebo. One capsule was taken immediately after the surgical procedure, followed by another capsule every 6 hours. The duration of treatment was 24 hours. Thus, a total of 4 capsules were taken. Self-evaluation forms were provided to the patients and were returned to the investigators the following day. The results were statistically analyzed. Both Fenbufen and ASA were statistically superior (p less than or equal to 0.01) to placebo in relieving pain. A comparison of the Fenbufen and ASA groups demonstrated a statistically significant (p less than or equal to 0.05) superiority for Fenbufen in relieving pain. Also sleep was less disturbed in the Fenbufen group. Side-effects reported were few, minor in character, and fewer in number in the Fenbufen group.
    Digital Access Access Options